Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc. Employee Directory

Biotechnology ResearchCalifornia, United States501-1000 Employees

Iovance Biotherapeutics, Inc. is a biotechnology company focused on developing tumor infiltrating lymphocyte (TIL) therapies for cancer patients. It aims to harness the immune system to recognize and destroy cancer cells in each individual, pursuing a per-patient treatment strategy. The TIL platform has produced clinical data suggesting activity across several solid tumor types, and the company continues to advance cell-therapy innovations, including gene-edited approaches. The firm is headquartered in the San Francisco Bay Area and operates the Iovance Cell Therapy Center manufacturing facility in Philadelphia, with a research site in Tampa, Florida. As it expands its commercial launch and research efforts, it is building internal manufacturing capabilities to support scale and execution. In 2025, the company appointed Corleen Roche as Chief Financial Officer, with the appointment effective in August 2025.

Find Iovance Biotherapeutics, Inc. employees' phone numbers or email addresses

Iovance Biotherapeutics, Inc. Global Highlights

Location
Employees

North America
978

Minus sign iconPlus sign icon
  • United States Of America
    974
  • Canada
    4

Europe
15

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    9
  • Netherlands
    4
  • Switzerland
    2

Asia
3

Minus sign iconPlus sign icon
  • India
    2
  • Iran
    1

Iovance Biotherapeutics, Inc.'s Leadership

  • Chief Financial Officer at Iovance Biotherapeutics, Inc.
    B. B.
    Chief Financial Officer
  • Vp Of Finance, Corporate Controller at Iovance Biotherapeutics, Inc.
    J. H.
    Vp Of Finance, Corporate Controller
  • Vice President Of Finance, Corporate Controller at Iovance Biotherapeutics, Inc.
    C. S.
    Vice President Of Finance, Corporate Controller
  • Executive Assistant To Chief Medical Officer at Iovance Biotherapeutics, Inc.
    C. A.
    Executive Assistant To Chief Medical Officer
  • Owner at Iovance Biotherapeutics, Inc.
    N. H.
    Owner
  • Executive Vice President, Quality at Iovance Biotherapeutics, Inc.
    K. S.
    Executive Vice President, Quality
  • Global Executive Medical Director (ex-Us) Til Therapy (immuno-Oncology) at Iovance Biotherapeutics, Inc.
    M. B.
    Global Executive Medical Director (ex-Us) Til Therapy (immuno-Oncology)
  • Human Resources Director at Iovance Biotherapeutics, Inc.
    E. G.
    Human Resources Director

Iovance Biotherapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Manufacturing
  • Operations
  • Quality Assurance
  • Engineering
  • Analytics
  • Other
  • Legal
  • Administrative
  • Biotechnology
  • Supply Chain

Contact profiles from Iovance Biotherapeutics, Inc.

Name
Title
Contact
Location
Last Update
  • Executive Director Clinical Operations at Iovance Biotherapeutics, Inc.
    E. A.
    Executive Director Clinical Operations
    Bay
    Sep 04, 2026
  • Senior Director Medical Affairs Europe/Exus at Iovance Biotherapeutics, Inc.
    S. H.
    Senior Director Medical Affairs Europe/Exus
    United Kingdom
    Mar 19, 2025
  • Program Leader, Director at Iovance Biotherapeutics, Inc.
    D. A. B.
    Program Leader, Director
    Bay
    Sep 04, 2026
  • Director, Regulatory Affairs Cmc at Iovance Biotherapeutics, Inc.
    K. A.
    Director, Regulatory Affairs Cmc
    Bay
    Jun 28, 2026
  • Executive Director at Iovance Biotherapeutics, Inc.
    A. B. H.
    Executive Director
    Jul 21, 2026
  • Senior Director, International Controller at Iovance Biotherapeutics, Inc.
    B. F.
    Senior Director, International Controller
    Netherlands, The Randstad
    Jul 10, 2026
  • Associate Director Cell Therapy at Iovance Biotherapeutics, Inc.
    B. W.
    Associate Director Cell Therapy
    Bay
    Jun 27, 2026
  • Associate Director, Field Medical Affairs (medical Science Liaison) at Iovance Biotherapeutics, Inc.
    K. A.
    Associate Director, Field Medical Affairs (medical Science Liaison)
    Jul 23, 2026
  • Director Of Risk Management, Drug Safety at Iovance Biotherapeutics, Inc.
    M. C.
    Director Of Risk Management, Drug Safety
    Bay
    Sep 04, 2026
  • Director, Commercial & Community Strategy at Iovance Biotherapeutics, Inc.
    N. G.
    Director, Commercial & Community Strategy
    Sep 04, 2026

Frequently Asked Questions

What is Iovance Biotherapeutics, Inc. known for?

Minus sign iconPlus sign icon
Iovance Biotherapeutics, Inc. was founded in 2007 and operates in the Biotechnology Research industry. You can contact Iovance Biotherapeutics, Inc.'s main corporate office by phone at . Explore Iovance Biotherapeutics, Inc.'s company overview page for more information.

What is Iovance Biotherapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
Iovance Biotherapeutics, Inc. employees' email format typically follows the pattern of First.Last@iovance.com. Trying to find reliable and up-to-date employee contact data? Find more Iovance Biotherapeutics, Inc. email formats with LeadIQ.

How many employees does Iovance Biotherapeutics, Inc. have currently?

Minus sign iconPlus sign icon
Iovance Biotherapeutics, Inc. has approximately 931 employees as of August 2026. These team members are located across 3 continents, including North America, Europe and Asia.

Who are Iovance Biotherapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Iovance Biotherapeutics, Inc.'s key employees include:

  • Chief Financial Officer: B. B.
  • Vp Of Finance, Corporate Controller: J. H.
  • Vice President Of Finance, Corporate Controller: C. S.
  • Executive Assistant To Chief Medical Officer: C. A.
  • Owner: N. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.